Efficacy of intravenous prourokinase and a combination of prourokinase and urokinase in acute myocardial infarction
- 1 May 1988
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 61 (13), 971-974
- https://doi.org/10.1016/0002-9149(88)90108-7
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Usefulness of intravenous thrombolytic therapy with pro-urokinase in acute myocardial infarctionThe American Journal of Cardiology, 1987
- Dose of urokinase for intracoronary thrombolysis in patients with acute myocardial infarctionClinical Cardiology, 1987
- Recombinant tissue plasminogen activator (rt-PA): Is it the thrombolytic agent of choice for an evolving acute myocardial infarction?The American Journal of Cardiology, 1987
- Coronary thrombolysis in patients with acute myocardial infarction by intravenous infusion of synergic thrombolytic agentsAmerican Heart Journal, 1986
- EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTIONThe Lancet, 1986
- Coronary thrombolysis in dogs with intravenously administered human pro-urokinase.Circulation, 1985
- The Thrombolysis in Myocardial Infarction (TIMI) TrialNew England Journal of Medicine, 1985
- Thrombolytic TherapyNew England Journal of Medicine, 1984
- Thrombolytic TherapyNew England Journal of Medicine, 1984
- Prevalence of Total Coronary Occlusion during the Early Hours of Transmural Myocardial InfarctionNew England Journal of Medicine, 1980